Shilpa Medicare gains on executing transfer agreement with Shilpa Pharma Lifesciences

04 Jul 2022 Evaluate

Shilpa Medicare is currently trading at Rs. 400.50, up by 3.90 points or 0.98% from its previous closing of Rs. 396.60 on the BSE.

The scrip opened at Rs. 400.65 and has touched a high and low of Rs. 405.70 and Rs. 399.55 respectively. So far 2710 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 670.95 on 22-Jul-2021 and a 52 week low of Rs. 380.35 on 07-Mar-2022.

Last one week high and low of the scrip stood at Rs. 420.60 and Rs. 381.30 respectively. The current market cap of the company is Rs. 3475.11 crore.

The promoters holding in the company stood at 50.01%, while Institutions and Non-Institutions held 16.34% and 33.65% respectively.

Shilpa Medicare has executed business transfer agreement with Shilpa Pharma Lifesciences (Formerly known as Shilpa Corporate Holdings) the transferee company which is complete and effective from June 30, 2022. With effect from closing of the transaction, Shilpa Pharma Lifesciences, a wholly owned subsidiary of Shilpa Medicare shall operate the API (Active Pharmaceutical Ingredient) business.

Shilpa Medicare produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.

Shilpa Medicare Share Price

842.30 -0.05 (-0.01%)
01-Nov-2024 18:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1858.70
Dr. Reddys Lab 1258.55
Cipla 1559.20
Lupin 2198.25
Zydus Lifesciences 1004.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.